Darrel P. Cohen's most recent trade in Viracta Therapeutics Inc was a trade of 120,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 12, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Viracta Therapeutics Inc | Darrel P. Cohen | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
Viracta Therapeutics Inc | Darrel P. Cohen | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2023 | 265,000 | 265,000 | - | - | Stock Option (Right to Buy) | |
Viracta Therapeutics Inc | Darrel P. Cohen | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2023 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) |